Jones Thomas, MD
Vascular Surgery · Oklahoma City, OKNPI 1871024349
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,016 of the $13,609 with a category attached, or 66.2%. 41 manufacturers reported payments, led by Medtronic at 37.7% of the total. Reporting peaked in 2024 at $4,916 and has fallen 80.8% since, to $944 in 2025.
Across 200 payments — averaging $68.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$2K
- Abbott$776
- Penumbra, Inc.$566
- Inari Medical, Inc.$561
- plus $3K from 35 others
What the payments were for
- Travel & lodging$4,42633%
- Food & beverage$9,01666%
- Education$1671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 67 | $5,136 |
| W. L. Gore & Associates, Inc. | 14 | $1,716 |
| Silk Road Medical, Inc. | 13 | $1,712 |
| Abbott | 8 | $776 |
| Penumbra, Inc. | 4 | $566 |
| Inari Medical, Inc. | 14 | $561 |
| Surmodics, Inc. | 13 | $455 |
| Endologix LLC | 4 | $345 |
| Centinel Spine, LLC | 2 | $334 |
| Bolton Medical Inc | 5 | $313 |
| Johnson & Johnson(3 entities) | 8 | $302 |
| Abiomed | 3 | $213 |
| Heartflow, Inc. | 1 | $147 |
| Shockwave Medical, Inc | 1 | $131 |
| Boston Scientific | 6 | $129 |
| Amgen | 6 | $108 |
| Merck | 3 | $62 |
| Actelion Pharmaceuticals US, Inc. | 3 | $62 |
| Stryker | 1 | $49 |
| Chiesi USA, Inc. | 2 | $41 |
| Polynovo North America LLC | 1 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $33 |
| Atricure, Inc. | 2 | $32 |
| Novartis | 1 | $26 |
| Edwards Lifesciences | 1 | $26 |
| Reflow Medical Inc | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Cook Medical LLC | 1 | $22 |
| Mozarc Medical US LLC | 1 | $21 |
| Cvrx, Inc. | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Centerline Biomedical Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Cagent Vascular Inc | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,556
- ENROUTE Transcarotid Stent$1,424
- Abre$1,168
- Valiant Captivia$1,103
- HARMONY$989
- GORE TAG Thoracic Endoprosthesis$806
- Indigo System$470
- FLOWTRIEVER CATHETER, S$337
- CT THROMBECTOMY SYSTEM KIT$337
- PRODISC L$334
- Supera peripheral stent system$298
- Alto Abdominal Stent Graft System$272
- C3 Delivery System$263
- ENDURANT IIS$254
- GORE VIABAHN VBX Balloon Expandable Endo$196
- Pounce Thrombectomy$178
- Pounce Venous Thrombectomy System$178
- Pounce Thrombectomy System$178
- Pounce LP Thrombectomy$178
- GORE-TEX Vascular Graft$167
How this compares
$13,609 in reported general payments places this provider in the 65th percentile of 35 vascular surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $25,661 |
| XareltoRivaroxaban | 25 | $22,561 |
| ClopidogrelClopidogrel Bisulfate | 62 | $609 |
| Gabapentin | 44 | $355 |
| Oxycodone Hcl | 62 | $161 |
| Atorvastatin Calcium | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $302 | $22,56125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 35 vascular surgery providers in Oklahoma.
Other vascular surgery in Oklahoma City
- Jim MeltonOklahoma City$131K
- Lenny StubbsOklahoma City$56K
- Ali AminOklahoma City$41K
- Bernardino RochaOklahoma City$34K
- Clifford HowellOklahoma City$17K
- Sherisa WarrenOklahoma City$15K
- Trenton KinnearOklahoma City$10K
- Donald SpadoneOklahoma City$9K
- James NeelOklahoma City$7K
- Whitney ThorneOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.